Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injury

American Journal of Nephrology

Volumn 40, Issue 1, 2014, Pages 1-11

  Bischoff, Ariane ^a   Bucher, Michael ^a   Gekle, Michael ^a   Sauvant, Christoph ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Acute renal failure; Cell transport; COX 1; Ischemia reperfusion; Physiology; Proximal tubular cells

Indexed keywords

4 AMINOHIPPURIC ACID; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; CASPASE 3; INULIN; MONOCYTE CHEMOTACTIC PROTEIN 1; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; 1-((4-METHYLSULFONYL)PHENYL)-3-TRIFLUOROMETHYL-5-(4-FLUOROPHENYL)PYRAZOLE; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; ORGANIC ANION TRANSPORTER; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; SLC22A6 PROTEIN, RAT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY PLASMA FLOW; KIDNEY TUBULE FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RENAL ARTERY; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; DRUG EFFECT; ENZYME ACTIVITY; KIDNEY CLEARANCE; POLYMERASE CHAIN REACTION; RAT; ANIMAL; CYTOLOGY; DRUG EFFECTS; GENETICS; KIDNEY; KIDNEY PROXIMAL TUBULE; METABOLISM;

ACUTE KIDNEY INJURY; ANIMALS; BLOTTING, WESTERN; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOWN-REGULATION; GLOMERULAR FILTRATION RATE; KIDNEY; KIDNEY TUBULES, PROXIMAL; ORGANIC ANION TRANSPORT PROTEIN 1; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; P-AMINOHIPPURIC ACID; PYRAZOLES; RATS; REPERFUSION INJURY; RNA, MESSENGER;

EID: 84902301843     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000363251     Document Type: Article

References (47)

1. Sauvant C, et al: Short-Term regulation of basolateral organic anion uptake in proximal tubular OK cells: Prostaglandin E 2 acts via receptor mediated activation of PKA. J Am Soc Nephrol 2003; 14: 3017-3026
2. Sauvant C, et al: Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia. Cell Physiol Biochem 2009; 24: 567-576
3. Sauvant C, et al: Prostaglandin E 2 inhibits its own renal transport by downregulation of organic anion transporters rOAT1 and rOAT3. J Am Soc Nephrol 2006; 17: 46-53
4. Raff U, et al: L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats. Nephron Physiol 2005; 101: 39-50
5. Schneider R, et al: L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 2003; 64: 216-225
6. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976; 72: 248-254
7. Sauvant C, et al: Indomethacin corrects alterations associated with ischemia/reperfusion in an in vitro proximal tubular model. Am J Nephrol 2010; 32: 57-65
8. Betz B, et al: Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury. PPAR Res 2012; 2012: 219319
9. Perri D, et al: The kidney-The body's playground for drugs: An overview of renal drug handling with selected clinical correlates. Can J Clin Pharmacol 2003; 10: 17-23
10. Van Montfoort JE, et al: Drug uptake systems in liver and kidney. Curr Drug Metab 2003; 4: 185-211
11. El-Sheikh AA, et al: Mechanisms of renal anionic drug transport. Eur J Pharmacol 2008; 585: 245-255
12. Dantzler WH: Renal organic anion transport: A comparative and cellular perspective. Biochim Biophys Acta 2002; 1566: 169-181
13. Wright SH, et al: Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84: 987-1049
14. Friis C: Renal transport and metabolism of xenobiotics. Acta Vet Scand 1991; 32: 33-43
15. Kusuhara H, et al: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 1999; 274: 13675-13680
16. Sweet DH, et al: Organic anion transporter-3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na + gradient. Am J Physiol Renal Physiol 2003; 284: F763-F769
17. Dantzler WH, et al: The molecular and cellular physiology of basolateral organic anion transport in mammalian renal tubules. Biochim Biophys Acta 2003; 1618: 185-193
18. Sekine T, et al: Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 2006; 290:F251-F261
19. Corrigan G, et al: PAH extraction and estimation of plasma flow in human postischemic acute renal failure. Am J Physiol 1999; 277: F312-F318
20. Schneider R, et al: Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-Aminohippurate after ischemic acute renal failure in rats. Am J Physiol Renal Physiol 2007; 292: F1599-F1605
21. Matsuzaki T, et al: Downregulation of organic anion transporters in rat kidney under ischemia/ reperfusion-induced acute renal failure. Kidney Int 2007; 71: 539-547
22. Di Giusto G, et al: Elimination of organic anions in response to an early stage of renal ischemia-reperfusion in the rat: Role of basolateral plasma membrane transporters and cortical renal blood flow. Pharmacology 2008; 81: 127-136
23. Tokuyama H, et al: Role of nitric oxide and prostaglandin E 2 in acute renal hypoperfusion. Nephrology (Carlton) 2003; 8: 65-71
24. Myers SI, et al: Suprarenal aortic clamping and reperfusion decreases medullary and cortical blood flow by decreased endogenous renal nitric oxide and PGE 2 synthesis. J Vasc Surg 2005; 42: 524-531
25. Tokuyama H, et al: Stenosis-dependent role of nitric oxide and prostaglandins in chronic renal ischemia. Am J Physiol Renal Physiol 2002; 282:F859-F865
26. Schneider R, et al: Low-dose indomethacin after ischemic acute kidney injury prevents down regulation of Oat1/3 and improves renal outcome. Am J Physiol Renal Physiol 2009; 297: F1614-F1621
27. Feitoza CQ, et al: Cyclooxygenase 1 and/or 2blockade ameliorates the renal tissue damage triggered by ischemia and reperfusion injury. Int Immunopharmacol 2005; 5: 79-84
28. Feitoza CQ, et al: Pretreatment with indomethacin protects from acute renal failure following ischemia-reperfusion injury. Transplant Proc 2002; 34: 2979-2980
29. Harris RC, et al: Cyclooxygenase metabolites in the kidney. Compr Physiol 2011; 1: 1729-1758
30. Bischoff A, et al: PAH clearance after renal ischemia and reperfusion is a function of impaired expression of basolateral Oat1 and Oat3. Physiol Rep 2014; 2: E00243
31. Sheridan AM, et al: Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Curr Opin Nephrol Hypertens 2000; 9: 427-434
32. Guan Z, et al: Renal endothelial dysfunction and impaired autoregulation after ischemiareperfusion injury result from excess nitric oxide. Am J Physiol Renal Physiol 2006; 291: F619-F628
33. Goligorsky MS, et al: Nitric oxide in acute renal failure: NOS versus NOS. Kidney Int 2002; 61: 855-861
34. Sung FL, et al: Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-?B. Kidney Int 2002; 62: 1160-1170
35. Smith CJ, et al: Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 1998; 95: 13313-13318
36. Miralpeix M, et al: Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: Biochemical and pharmacological characterization. Br J Pharmacol 1997; 121: 171-180
37. Anderson GD, et al: Selective inhibition of COX-2 reverses inflammation and expression of COX-2 and interleukin-6 in rat adjuvant arthritis. J Clin Invest 1996; 97: 2672-2679
38. Cox PG, et al: Accumulation of salicylic acid and indomethacin in isolated proximal tubular cells of the rat kidney. Pharmacol Res 1993; 27: 241-252
39. Hocherl K, et al: COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex. Kidney Int 2009; 75: 373-380
40. Mehta V, et al: Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous system. Clin Pharmacol Ther 2008; 83: 430-435
41. Russ AL, et al: Experimental strategies to improve in vitro models of renal ischemia. Exp Mol Pathol 2007; 83: 143-159
42. Kinsey GR, et al: Inflammation in acute kidney injury. Nephron Exp Nephrol 2008; 109: E102-e107
43. Bonventre JV, et al: Ischemic acute renal failure: An inflammatory disease?. Kidney Int 2004; 66: 480-485
44. Kim SJ, et al: Mechanism of reduced GFR in rabbits with ischemic acute renal failure. Ren Fail 2000; 22: 129-141
45. Araujo M, et al: Tubuloglomerular feedback is decreased in COX-1 knockout mice after chronic angiotensin II infusion. Am J Physiol Renal Physiol 2010; 298:F1059-F1063
46. Araujo M, et al: Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: Roles of thromboxane receptors and nitric oxide. Am J Physiol Renal Physiol 2009; 296: F790-F794
47. Qi Z, et al: Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest 2002; 110: 61-69